IMS Health acquires HGS Europe

Share this article:

IMS Health brought market access firm HGS Europe into the fold last month.

The UK company, which was founded in 1998 by Angela and Graeme McFarland, has expertise in understanding the market access piece of a launch as well as what cost-effectiveness ­gatekeepers such as NICE are looking for.

Mike Sanvoisin, the GM of UK and Ireland for IMS, told MM&M that IMS will be looking to link its own real-world data assets with HGS's strategies in order to help European payers see how drugs are performing in the real world. “Payers want to see that investments they make are having an effect,” Sanvoisi said. “That's where we see the synergy of HGS coming in.”

Share this article:

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.